English | 繁體

Search in the results

UM

Browse/Search Results:  1-2 of 2 Help

Selected(0)Clear Items/Page:    Sort:
Non-classical estrogen signaling in ovarian cancer improves chemo-sensitivity and patients outcome Journal article
HAO, DP, LI, JJ, WANG, JL, ZHAO, ZQ, Wang, L., Di, L.. Non-classical estrogen signaling in ovarian cancer improves chemo-sensitivity and patients outcome[J]. Theranostics, 2019, 3952-3965.
Authors:  HAO, DP;  LI, JJ;  WANG, JL;  ZHAO, ZQ;  Wang, L.; et al.
Favorite |   IF:12.4/12.0 | Submit date：2023/08/30
Ovarian cancer  Estrogen signaling  Deficiency of homologous-recombination  Chemotherapy  Hormone replacement  
Non-classical estrogen signaling in ovarian cancer improves chemo-sensitivity and patients outcome Journal article
Dapeng Hao, Jingjing Li, Jianlin Wang, Yuan Meng, Zhiqiang Zhao, Chao Zhang, Kai Miao, Chuxia Deng, Benjamin K. Tsang, Li Wang, Li-jun Di. Non-classical estrogen signaling in ovarian cancer improves chemo-sensitivity and patients outcome[J]. THERANOSTICS, 2019, 9(13), 3952-3965.
Authors:  Dapeng Hao;  Jingjing Li;  Jianlin Wang;  Yuan Meng;  Zhiqiang Zhao; et al.
Favorite | TC[WOS]:15 TC[Scopus]:15  IF:12.4/12.0 | Submit date：2020/05/21
Ovarian Cancer  Estrogen Signaling  Deficiency Of Homologous-recombination  Chemotherapy  Hormone Replacement